Press Room

17Jun17

Great Success of the "Phase I Clinical Trials in Spain" Session organized by KYMOS and the IFTH

KYMOS is a proud to have been the sponsor and coorganizer of the "Phase I Clinical Trials in Spain" Session. The event took place on June 14 in the Barcelona Sicence Park and had a great success with around 100 attendees. KYMOS' CEO, Joan Puig de Dou, welcomed and farewelled the participants. Other KYMOS team members participate during the event: Lluisa Garcia (COO) moderated a roundtable and Jaume Pascual (Scientific Director Small Molecules) and Carles Celma (Scientific Director Biologics) exhibited very interesting scientific presentations.

08Jun17

Kymos takes part of 57 Simposium AFI at Rimini, June 7-9, 2017

KYMOS participates in the yearly conference of the Italian Association of Industry Pharmacists (AFI) in Rimini. KYMOS and its Italian affiliate PHARMAPROGRESS take up the stand #8 showing up its analytical capabilities in small molecules and biologics.

04Jun17

Kymos coordination of ICH Q3D course in the framework of IL3 UB program

Jaume Pascual, Scientifc Director of Kymos, coordinated a course of IL3 (Barcelona University) about the guideline ICH Q3D on Elemental Impurities. The course took place at Barcelona, the last 1st of June with a lot of success and more of 75 attendants.

09May17

Revisions of Medical Device Directives

On 5 April, the European Parliament and the Council are adopted two new Regulations on medical devices: Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746 on in vitro diagnostic medical devices. The new rules will only apply after a